“Safety and Efficacy of a Fixed Combination Halobetasol Propionate 0.01%/Tazarotene 0.045% (HP/TAZ) Lotion in the Treatment of Females With Moderate-to-Severe Plaque Psoriasis” (2020) SKIN The Journal of Cutaneous Medicine, 4(1), p. S9. Available at: https://skin.dermsquared.com/skin/article/view/822 (Accessed: 19 April 2025).